In Due Diligence Searches For Prior Art,The Patent Office Simply Does Not Compute

Yogi Berra's classic line, "It's deja vu all over again," came to mind as I read a story on the United States Patent Office fiasco regarding the Compton's New Media case (S. Chartrand, "At the Patent Office, a digital dawn," New York Times, Nov. 12, 1994, page 39). To recap: In August 1993 the Patent Office awarded Compton's, a San Diego-based CD-ROM publisher, exclusive rights on a basic search and retrieval software feature in its interactive CD-ROM products. This would have allowed C

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

To recap: In August 1993 the Patent Office awarded Compton's, a San Diego-based CD-ROM publisher, exclusive rights on a basic search and retrieval software feature in its interactive CD-ROM products. This would have allowed Compton's to demand licensing or royalty fees from virtually any company in the CD-ROM industry. However, last October the Compton's patent was invalidated. After a more careful examination, the Patent Office found dozens of documents indicating the "invention" was neither new nor unique. It is indeed ironic that this obvious failure in searching "prior art" involved a retrieval software patent application.

The sense of deja vu arises from my own experience with the Patent Office and its efforts at computerization more than 35 years ago. In 1957, the office was swamped by a flood of patent applications on steroids, then a very active field of research and commercialization. In order to alleviate the huge backlog, the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Eugene Garfield

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo